Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > IntelGenx (IGXT) versus Ceapro (CZO): CZO is Dirt Cheap

<< Previous

Bullboard Posts

Next >>

Comment by stockfyon Aug 11, 2021 2:51pm

76 Views

Post# 33685962

RE:IntelGenx (IGXT) versus Ceapro (CZO): CZO is Dirt Cheap

boazklinghorn, you must be kidding. If you really like IGNX's balance sheet and the latest quarterly results, you have to attend a basic course on investing asap. Check its latest results again:

https://www.stocktitan.net/news/IGXT/intel-genx-reports-second-quarter-2021-financial-9oose8ws49ed.html

stockfy wrote:

IGXT's Enterprise Value currently is about $60 million (including its cash and the latest debt=notes) while CZO's Enterprise Value (including its cash and zero debt) currently is only $45 million.

Meanwhile, IGXT's ugly results are below:

https://www.stocktitan.net/news/IGXT/intel-genx-reports-second-quarter-2021-financial-9oose8ws49ed.html

CZO's excellent results are below:

https://www.globenewswire.com/en/news-release/2021/05/20/2233469/0/en/Ceapro-Inc-Reports-2021-First-Quarter-Financial-Results-and-Highlights.html